PRIORY MEDICAL GROUP — All Prescriptions & Medications — Page 12
Practice Code: B82005 | YORK, YO24 3WX
Showing results 551-600 of 935
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Prednisolone sodium phosphate | 65 | 2,310 | £1.3K | +409.6% ▲ |
| 65 | 6,420 | £1.0K | +142.0% ▲ | |
| Valaciclovir | 64 | 1,956 | £2.4K | +355.4% ▲ |
| 64 | 940 | £2.9K | +214.3% ▲ | |
| 64 | 3,180 | £7.3K | +320.2% ▲ | |
| Ipratropium bromide | 63 | 459 | £535 | +119.2% ▲ |
| Dienogest | 63 | 2,184 | £1.5K | +770.0% ▲ |
| Zinc oxide | 63 | 14.1K | £428 | +213.3% ▲ |
| 62 | 3,020 | £2.2K | +87.5% ▲ | |
| Acetazolamide | 61 | 4,146 | £164 | +181.5% ▲ |
| Ketoconazole | 61 | 2,160 | £291 | +513.2% ▲ |
| 61 | 3,240 | £2.0K | +340.3% ▲ | |
| Mebeverine hydrochloride compound preparations | 60 | 2,266 | £2.0K | +430.7% ▲ |
| Sotalol hydrochloride | 60 | 5,040 | £151 | -14.7% ▼ |
| Levonorgestrel | 60 | 91 | £292 | +1,388.7% ▲ |
| Triamcinolone acetonide | 60 | 155 | £214 | -19.8% ▼ |
| Formoterol fumarate | 59 | 82 | £2.0K | +311.5% ▲ |
| Brivaracetam | 59 | 3,450 | £7.4K | +73.4% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 59 | 2,048 | £1.1K | +129.7% ▲ |
| Brinzolamide/brimonidine | 59 | 405 | £711 | +72.0% ▲ |
| Diclofenac sodium | 59 | 3,300 | £2.4K | +146.2% ▲ |
| 59 | 138 | £12.5K | +719.1% ▲ | |
| 58 | 2,180 | £10.5K | +28.3% ▲ | |
| Powder thickener - starch based (0913161) | 57 | 24.8K | £667 | +296.8% ▲ |
| Fusidic acid | 57 | 290 | £1.0K | +451.8% ▲ |
| Ciprofloxacin | 57 | 915 | £349 | +518.3% ▲ |
| Atomoxetine hydrochloride | 56 | 1,904 | £3.7K | +65.6% ▲ |
| Darifenacin hydrobromide | 56 | 1,792 | £1.6K | +71.8% ▲ |
| Dantrolene sodium | 56 | 952 | £340 | +210.5% ▲ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 55 | 193.8K | £1.2K | +171.9% ▲ |
| 55 | 1,099 | £2.2K | +112.3% ▲ | |
| 55 | 1,775 | £533 | +64.8% ▲ | |
| Fluvastatin sodium | 54 | 2,352 | £306 | +133.5% ▲ |
| Rimegepant | 54 | 378 | £4.9K | +450.5% ▲ |
| Ryeqo | 54 | 1,932 | £4.7K | +859.3% ▲ |
| 54 | 1,124 | £1.4K | +37.0% ▲ | |
| 53 | 157 | £1.5K | +345.3% ▲ | |
| 53 | 4,216 | £9.8K | +200.6% ▲ | |
| Bempedoic acid/Ezetimibe | 52 | 1,792 | £3.4K | -14.8% ▼ |
| Lurasidone | 52 | 364 | £994 | +108.4% ▲ |
| Clindamycin hydrochloride | 52 | 4,428 | £1.0K | +419.4% ▲ |
| Ipratropium bromide | 52 | 62 | £436 | +220.7% ▲ |
| Mupirocin | 52 | 990 | £495 | +460.1% ▲ |
| Malathion | 52 | 12.5K | £1.1K | +714.2% ▲ |
| Other individually formulated bought in preparations | 52 | 2,958 | £1.7K | +59.2% ▲ |
| Ethosuximide | 51 | 18.5K | £20.8K | +245.7% ▲ |
| 51 | 1,190 | £6.6K | +308.4% ▲ | |
| Inclisiran | 50 | 50 | £2.3K | +296.9% ▲ |
| Citalopram hydrochloride | 49 | 885 | £613 | +205.3% ▲ |
| Denosumab | 49 | 49 | £8.9K | +80.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.